From Hurdles to Breakthroughs: Building and Validating a PSMA-positive Triple-Negative Breast Cancer Mouse Model for Preclinical Targeted Radionuclide TherapyBenjamin Chaussin, E. Jouberton|Research Square|2025Cited by 0
Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapiesBenjamin Chaussin, E. Jouberton|Scientific Reports|2026Cited by 0